THE Therapeutic Goods
Administration has published new
Australian Public Assessment
Reports detailing the prescription
medicine application and approval
process for Abatacept (rch),
Ropivacaine and Telmisartan.The above snippet is the first part of an article sent to subscribers in Pharmacy Daily's issue from 29 Apr 10 To see the full story, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 29 Apr 10
LEADING pharmacy, consumer and Federal agencies want to see better use of existing funding and leverage digital health resources to improve quality use of medicines, discussions at the Medicines Safety Forum in Canberra revealed.